HEK293 Cell Transfection Reagent - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB510248181

Publication Date:

October 22, 2024

Pages:

140

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

HEK293 Cell Transfection Reagent is a unique formulation based on polycationic liposomes of non-animal origin. It is suitable for large-scale transient transfection of HEK293 cells to produce recombinant proteins, monoclonal antibodies, virus particles (AAV, adenovirus, lentivirus), and virus-like particles.
The global market for HEK293 Cell Transfection Reagent was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Increasing demand for HEK293 cell line research, development of biomedical research technologies, clinical application of gene expression, cell analysis, and drug screening, and continuous regulation across the biopharmaceutical industry are the key factors driving the growth of HEK293 cell transfection reagents market revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for HEK293 Cell Transfection Reagent, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of HEK293 Cell Transfection Reagent by region & country, by Type, and by Application.
The HEK293 Cell Transfection Reagent market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HEK293 Cell Transfection Reagent.
麻豆原创 Segmentation
By Company
Sigma Aldrich
Thermo Fisher Scientific
Merck
Altogen Biosystems
SPEED Biosystems
Mirus Bio
OriGene
Bio-protocol
Novagen
Biontex
HAL
GeneDireX
BOC Sciences
Agilent
Beijing T and L Biotechnology
Sino Biological
Shanghai Biyuntian Biotechnology
Segment by Type:
1 ml
10 ml
100 ml
Segment by Application
Gene Expression
Cell Analysis
Protein And Virus Production
Drug Screening
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of HEK293 Cell Transfection Reagent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of HEK293 Cell Transfection Reagent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of HEK293 Cell Transfection Reagent in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 HEK293 Cell Transfection Reagent Product Introduction
1.2 Global HEK293 Cell Transfection Reagent 麻豆原创 Size Forecast
1.2.1 Global HEK293 Cell Transfection Reagent Sales Value (2019-2030)
1.2.2 Global HEK293 Cell Transfection Reagent Sales Volume (2019-2030)
1.2.3 Global HEK293 Cell Transfection Reagent Sales Price (2019-2030)
1.3 HEK293 Cell Transfection Reagent 麻豆原创 Trends & Drivers
1.3.1 HEK293 Cell Transfection Reagent Industry Trends
1.3.2 HEK293 Cell Transfection Reagent 麻豆原创 Drivers & Opportunity
1.3.3 HEK293 Cell Transfection Reagent 麻豆原创 Challenges
1.3.4 HEK293 Cell Transfection Reagent 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global HEK293 Cell Transfection Reagent Players Revenue Ranking (2023)
2.2 Global HEK293 Cell Transfection Reagent Revenue by Company (2019-2024)
2.3 Global HEK293 Cell Transfection Reagent Players Sales Volume Ranking (2023)
2.4 Global HEK293 Cell Transfection Reagent Sales Volume by Company Players (2019-2024)
2.5 Global HEK293 Cell Transfection Reagent Average Price by Company (2019-2024)
2.6 Key Manufacturers HEK293 Cell Transfection Reagent Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers HEK293 Cell Transfection Reagent Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of HEK293 Cell Transfection Reagent
2.9 HEK293 Cell Transfection Reagent 麻豆原创 Competitive Analysis
2.9.1 HEK293 Cell Transfection Reagent 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by HEK293 Cell Transfection Reagent Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HEK293 Cell Transfection Reagent as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 1 ml
3.1.2 10 ml
3.1.3 100 ml
3.2 Global HEK293 Cell Transfection Reagent Sales Value by Type
3.2.1 Global HEK293 Cell Transfection Reagent Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global HEK293 Cell Transfection Reagent Sales Value, by Type (2019-2030)
3.2.3 Global HEK293 Cell Transfection Reagent Sales Value, by Type (%) (2019-2030)
3.3 Global HEK293 Cell Transfection Reagent Sales Volume by Type
3.3.1 Global HEK293 Cell Transfection Reagent Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global HEK293 Cell Transfection Reagent Sales Volume, by Type (2019-2030)
3.3.3 Global HEK293 Cell Transfection Reagent Sales Volume, by Type (%) (2019-2030)
3.4 Global HEK293 Cell Transfection Reagent Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Gene Expression
4.1.2 Cell Analysis
4.1.3 Protein And Virus Production
4.1.4 Drug Screening
4.1.5 Others
4.2 Global HEK293 Cell Transfection Reagent Sales Value by Application
4.2.1 Global HEK293 Cell Transfection Reagent Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global HEK293 Cell Transfection Reagent Sales Value, by Application (2019-2030)
4.2.3 Global HEK293 Cell Transfection Reagent Sales Value, by Application (%) (2019-2030)
4.3 Global HEK293 Cell Transfection Reagent Sales Volume by Application
4.3.1 Global HEK293 Cell Transfection Reagent Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global HEK293 Cell Transfection Reagent Sales Volume, by Application (2019-2030)
4.3.3 Global HEK293 Cell Transfection Reagent Sales Volume, by Application (%) (2019-2030)
4.4 Global HEK293 Cell Transfection Reagent Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global HEK293 Cell Transfection Reagent Sales Value by Region
5.1.1 Global HEK293 Cell Transfection Reagent Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global HEK293 Cell Transfection Reagent Sales Value by Region (2019-2024)
5.1.3 Global HEK293 Cell Transfection Reagent Sales Value by Region (2025-2030)
5.1.4 Global HEK293 Cell Transfection Reagent Sales Value by Region (%), (2019-2030)
5.2 Global HEK293 Cell Transfection Reagent Sales Volume by Region
5.2.1 Global HEK293 Cell Transfection Reagent Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global HEK293 Cell Transfection Reagent Sales Volume by Region (2019-2024)
5.2.3 Global HEK293 Cell Transfection Reagent Sales Volume by Region (2025-2030)
5.2.4 Global HEK293 Cell Transfection Reagent Sales Volume by Region (%), (2019-2030)
5.3 Global HEK293 Cell Transfection Reagent Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America HEK293 Cell Transfection Reagent Sales Value, 2019-2030
5.4.2 North America HEK293 Cell Transfection Reagent Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe HEK293 Cell Transfection Reagent Sales Value, 2019-2030
5.5.2 Europe HEK293 Cell Transfection Reagent Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific HEK293 Cell Transfection Reagent Sales Value, 2019-2030
5.6.2 Asia Pacific HEK293 Cell Transfection Reagent Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America HEK293 Cell Transfection Reagent Sales Value, 2019-2030
5.7.2 South America HEK293 Cell Transfection Reagent Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa HEK293 Cell Transfection Reagent Sales Value, 2019-2030
5.8.2 Middle East & Africa HEK293 Cell Transfection Reagent Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions HEK293 Cell Transfection Reagent Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions HEK293 Cell Transfection Reagent Sales Value
6.2.1 Key Countries/Regions HEK293 Cell Transfection Reagent Sales Value, 2019-2030
6.2.2 Key Countries/Regions HEK293 Cell Transfection Reagent Sales Volume, 2019-2030
6.3 United States
6.3.1 United States HEK293 Cell Transfection Reagent Sales Value, 2019-2030
6.3.2 United States HEK293 Cell Transfection Reagent Sales Value by Type (%), 2023 VS 2030
6.3.3 United States HEK293 Cell Transfection Reagent Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe HEK293 Cell Transfection Reagent Sales Value, 2019-2030
6.4.2 Europe HEK293 Cell Transfection Reagent Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe HEK293 Cell Transfection Reagent Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China HEK293 Cell Transfection Reagent Sales Value, 2019-2030
6.5.2 China HEK293 Cell Transfection Reagent Sales Value by Type (%), 2023 VS 2030
6.5.3 China HEK293 Cell Transfection Reagent Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan HEK293 Cell Transfection Reagent Sales Value, 2019-2030
6.6.2 Japan HEK293 Cell Transfection Reagent Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan HEK293 Cell Transfection Reagent Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea HEK293 Cell Transfection Reagent Sales Value, 2019-2030
6.7.2 South Korea HEK293 Cell Transfection Reagent Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea HEK293 Cell Transfection Reagent Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia HEK293 Cell Transfection Reagent Sales Value, 2019-2030
6.8.2 Southeast Asia HEK293 Cell Transfection Reagent Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia HEK293 Cell Transfection Reagent Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India HEK293 Cell Transfection Reagent Sales Value, 2019-2030
6.9.2 India HEK293 Cell Transfection Reagent Sales Value by Type (%), 2023 VS 2030
6.9.3 India HEK293 Cell Transfection Reagent Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Sigma Aldrich
7.1.1 Sigma Aldrich Company Information
7.1.2 Sigma Aldrich Introduction and Business Overview
7.1.3 Sigma Aldrich HEK293 Cell Transfection Reagent Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Sigma Aldrich HEK293 Cell Transfection Reagent Product Offerings
7.1.5 Sigma Aldrich Recent Development
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Company Information
7.2.2 Thermo Fisher Scientific Introduction and Business Overview
7.2.3 Thermo Fisher Scientific HEK293 Cell Transfection Reagent Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Thermo Fisher Scientific HEK293 Cell Transfection Reagent Product Offerings
7.2.5 Thermo Fisher Scientific Recent Development
7.3 Merck
7.3.1 Merck Company Information
7.3.2 Merck Introduction and Business Overview
7.3.3 Merck HEK293 Cell Transfection Reagent Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Merck HEK293 Cell Transfection Reagent Product Offerings
7.3.5 Merck Recent Development
7.4 Altogen Biosystems
7.4.1 Altogen Biosystems Company Information
7.4.2 Altogen Biosystems Introduction and Business Overview
7.4.3 Altogen Biosystems HEK293 Cell Transfection Reagent Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Altogen Biosystems HEK293 Cell Transfection Reagent Product Offerings
7.4.5 Altogen Biosystems Recent Development
7.5 SPEED Biosystems
7.5.1 SPEED Biosystems Company Information
7.5.2 SPEED Biosystems Introduction and Business Overview
7.5.3 SPEED Biosystems HEK293 Cell Transfection Reagent Sales, Revenue and Gross Margin (2019-2024)
7.5.4 SPEED Biosystems HEK293 Cell Transfection Reagent Product Offerings
7.5.5 SPEED Biosystems Recent Development
7.6 Mirus Bio
7.6.1 Mirus Bio Company Information
7.6.2 Mirus Bio Introduction and Business Overview
7.6.3 Mirus Bio HEK293 Cell Transfection Reagent Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Mirus Bio HEK293 Cell Transfection Reagent Product Offerings
7.6.5 Mirus Bio Recent Development
7.7 OriGene
7.7.1 OriGene Company Information
7.7.2 OriGene Introduction and Business Overview
7.7.3 OriGene HEK293 Cell Transfection Reagent Sales, Revenue and Gross Margin (2019-2024)
7.7.4 OriGene HEK293 Cell Transfection Reagent Product Offerings
7.7.5 OriGene Recent Development
7.8 Bio-protocol
7.8.1 Bio-protocol Company Information
7.8.2 Bio-protocol Introduction and Business Overview
7.8.3 Bio-protocol HEK293 Cell Transfection Reagent Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Bio-protocol HEK293 Cell Transfection Reagent Product Offerings
7.8.5 Bio-protocol Recent Development
7.9 Novagen
7.9.1 Novagen Company Information
7.9.2 Novagen Introduction and Business Overview
7.9.3 Novagen HEK293 Cell Transfection Reagent Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Novagen HEK293 Cell Transfection Reagent Product Offerings
7.9.5 Novagen Recent Development
7.10 Biontex
7.10.1 Biontex Company Information
7.10.2 Biontex Introduction and Business Overview
7.10.3 Biontex HEK293 Cell Transfection Reagent Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Biontex HEK293 Cell Transfection Reagent Product Offerings
7.10.5 Biontex Recent Development
7.11 HAL
7.11.1 HAL Company Information
7.11.2 HAL Introduction and Business Overview
7.11.3 HAL HEK293 Cell Transfection Reagent Sales, Revenue and Gross Margin (2019-2024)
7.11.4 HAL HEK293 Cell Transfection Reagent Product Offerings
7.11.5 HAL Recent Development
7.12 GeneDireX
7.12.1 GeneDireX Company Information
7.12.2 GeneDireX Introduction and Business Overview
7.12.3 GeneDireX HEK293 Cell Transfection Reagent Sales, Revenue and Gross Margin (2019-2024)
7.12.4 GeneDireX HEK293 Cell Transfection Reagent Product Offerings
7.12.5 GeneDireX Recent Development
7.13 BOC Sciences
7.13.1 BOC Sciences Company Information
7.13.2 BOC Sciences Introduction and Business Overview
7.13.3 BOC Sciences HEK293 Cell Transfection Reagent Sales, Revenue and Gross Margin (2019-2024)
7.13.4 BOC Sciences HEK293 Cell Transfection Reagent Product Offerings
7.13.5 BOC Sciences Recent Development
7.14 Agilent
7.14.1 Agilent Company Information
7.14.2 Agilent Introduction and Business Overview
7.14.3 Agilent HEK293 Cell Transfection Reagent Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Agilent HEK293 Cell Transfection Reagent Product Offerings
7.14.5 Agilent Recent Development
7.15 Beijing T and L Biotechnology
7.15.1 Beijing T and L Biotechnology Company Information
7.15.2 Beijing T and L Biotechnology Introduction and Business Overview
7.15.3 Beijing T and L Biotechnology HEK293 Cell Transfection Reagent Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Beijing T and L Biotechnology HEK293 Cell Transfection Reagent Product Offerings
7.15.5 Beijing T and L Biotechnology Recent Development
7.16 Sino Biological
7.16.1 Sino Biological Company Information
7.16.2 Sino Biological Introduction and Business Overview
7.16.3 Sino Biological HEK293 Cell Transfection Reagent Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Sino Biological HEK293 Cell Transfection Reagent Product Offerings
7.16.5 Sino Biological Recent Development
7.17 Shanghai Biyuntian Biotechnology
7.17.1 Shanghai Biyuntian Biotechnology Company Information
7.17.2 Shanghai Biyuntian Biotechnology Introduction and Business Overview
7.17.3 Shanghai Biyuntian Biotechnology HEK293 Cell Transfection Reagent Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Shanghai Biyuntian Biotechnology HEK293 Cell Transfection Reagent Product Offerings
7.17.5 Shanghai Biyuntian Biotechnology Recent Development
8 Industry Chain Analysis
8.1 HEK293 Cell Transfection Reagent Industrial Chain
8.2 HEK293 Cell Transfection Reagent Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 HEK293 Cell Transfection Reagent Sales Model
8.5.2 Sales Channel
8.5.3 HEK293 Cell Transfection Reagent Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Sigma Aldrich
Thermo Fisher Scientific
Merck
Altogen Biosystems
SPEED Biosystems
Mirus Bio
OriGene
Bio-protocol
Novagen
Biontex
HAL
GeneDireX
BOC Sciences
Agilent
Beijing T and L Biotechnology
Sino Biological
Shanghai Biyuntian Biotechnology

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.